ArticleCytotechnology2026
Pulsed radiofrequency therapy ameliorates steroid-induced osteonecrosis of the femoral head by promoting nerve growth factor production.
Article in Cytotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulsed Radiofrequency for Post-Stroke Complications: From Neuromodulation to Functional Recovery.Current neurology and neuroscience reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steroid-induced osteonecrosis of the femoral head (SONFH) is characterized by devastating collapse of the femoral head. Pulsed radiofrequency therapy (PRF) has been widely used in different pathophysiological conditions. Here, we investigated the therapeutic benefit of PRF in SONFH and investigated the role of neurotrophins in the treatment effect of PRF therapy. The beneficial effect of PRF therapy in SONFH patients and the rat model of SONFH was evaluated. The effect of PRF therapy on the levels of neutrotropic factors was examined by ELISA. The functional engagement of nerve growth factor (NGF) in alleviating SONFH progression was investigated in the bone marrow cells and animal model. PRF alleviated SONFH progression in the patients and rat model. PRF therapy increased the plasma levels of NGF in SONFH patients and rat model. NGF treatment prevented Dex-induced cell death and steatosis in bone marrow cells, promoted the expression of osteogenic markers, and ameliorated SONFH progression in the rat model. NGF neutralization counteracted the effect of PRF therapy in the rat model of SONFH. Our findings suggest that PFR therapy ameliorates SONFH progression by promoting NGF production. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-025-00871-y.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.